|Day Low/High||3.35 / 3.50|
|52 Wk Low/High||2.48 / 21.00|
- Estate Covers over 175 Patents for Physiocrine Biology, a New Class of Potential Targets and Therapeutics -
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Here's a technical look at how to trade five stocks that are within range of triggering big breakouts.
Insiders at these companies have been scooping up shares of their own stock lately.
Shares of aTyr Pharma (LIFE) are climbing late Tuesday afternoon as BMO Capital began coverage of the stock with a ‘market perform’ rating and $8 price target.
These stocks look ready to break out and trade higher from current levels.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
The research firm believes the insurance industry is reasonably healthy, but it is confronted by several challenges Jefferies analyst Colin Devine initiated coverage on the shares of Prudential Fin...
Investors considering a purchase of Life Technologies Corp shares, but tentative about paying the going market price of $75.97/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February put at the $75 strike, which has a bid at the time of this writing of 5 cents.
Trade-Ideas LLC identified Life Technologies (LIFE) as a new lifetime high candidate
GE is helping Thermo Fisher satisfy antitrust regulators by buying some of its units. It's a 'man bites dog' story.
General Electric on Monday continued its push to expand its healthcare operation, agreeing to acquire certain life science assets of Thermo Fisher Scientific for $1.06 billion in cash.
James Dennin, Kapitall: The Swiss rejected a measure to cap CEO pay ratios. We took a closer look at stocks [...]
Life Technologies (Nasdaq:LIFE) has been downgraded by TheStreet Ratings from from a buy to hold.
Upgrades: EXFO, LYTS, UNAM Downgrades: LIFE, PRXI, QGEN Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
Trade-Ideas LLC identified Life Technologies (LIFE) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
U.S. stock futures are suggesting some stabilization in equities after their sharpest decline in eight weeks.
Life Technologies (Nasdaq:LIFE) hit a new 52-week high Wednesday as it is currently trading at $74.50, above its previous 52-week high of $74.48 with 1.5 million shares traded as of 3:31 p.m. ET. Average volume has been four million shares over the past 30 days.